Concord Medical Services Holdings EBITDA Growth & History (CCM)

Concord Medical Services Holdings's calculated EBITDA was −¥121.9M for fiscal 2025.

View full Concord Medical Services Holdings company overview

Concord Medical Services Holdings annual ebitda history

Concord Medical Services Holdings annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20252025-12-31−¥121.9M¥289.2M
20242024-12-31−¥411.0M−¥66.9M
20232023-12-31−¥344.2M¥57.7M
20222022-12-31−¥401.9M−¥38.0M
20212021-12-31−¥363.9M−¥118.6M
20202020-12-31−¥245.2M¥135.7M
20192019-12-31−¥380.9M−¥126.7M
20182018-12-31−¥254.2M−¥131.8M
20172017-12-31−¥122.4M−¥81.6M
20162016-12-31−¥40.8M−¥192.3M
20152015-12-31¥151.5M−¥230.2M−60.31%
20142014-12-31¥381.7M¥45.8M+13.63%
20132013-12-31¥335.9M¥5.4M+1.64%
20122012-12-31¥330.5M¥371.9M
20112011-12-31−¥41.4M−¥330.5M
20102010-12-31¥289.0M¥43.5M+17.71%
20092009-12-31¥245.6M

Concord Medical Services Holdings ebitda trends

Over the last five reported fiscal years, Concord Medical Services Holdings's ebitda increased from −¥245.2M to −¥121.9M, a change of ¥123.4M.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Concord Medical Services Holdings filings at SEC.gov ↗